Press Release – New Partnership

Technopath Distribution is proud to announce our new partnership with Baebies for the supply and support of their newborn screening solution in Ireland and the U.K.
Guided by the vision that “everyone deserves a healthy start,” Baebies mission is to save lives and make lives better for all by bringing new technologies, new tests, and new hope to children, parents, adult patients, and healthcare professionals worldwide.

The SEEKER® workstation is the first CE-marked newborn screening platform for lysosomal storage disorders using digital microfluidic technology. SEEKER® quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of MPS I, Pompe, Gaucher and Fabry.

The team at Technopath Distribution look forward to working with Baebies to support our customers with these product solutions to enable early disease detection for newborns.

About Baebies
Baebies is a medical device company that develops and commercialises newborn screening and near-patient testing products for children and adults to enable early disease detection and comprehensive diagnosis. Their core technology is driven by digital microfluidics, which allows for shorter testing times using microlitre-sized samples. Baebies has delivered over 12 million tests to date – every test being a chance to save a life. Their innovative products are designed for both central laboratories and point-of-care settings to maximise clinical impact for all.
Baebies is headquartered in Durham, North Carolina, USA. For more information, visit baebies.com and follow them on LinkedIn, Twitter, and YouTube.